Isabelle Ayoub is a Nephrology physician affiliated with The Ohio State University. OpenAlex indexes 115 publications with 2,899 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
543 Taylor Ave
Columbus, OH 432031278
Telephone
614-293-4837Provider last certified this registry record 2 Jan 2025.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202510 payments$16,714openpaymentsdata.cms.gov ↗
- Travere Therapeutics, Inc.Program year202515 payments$11,808openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
54.4%Angiotensin receptor blocker (ARB)20%Losartan Potassium80%Valsartan20%Part D<11 patientsAldosterone antagonist (MRA)11.5%Spironolactone100%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
19%SGLT2 inhibitor10.8%Farxiga67%Jardiance33%Part D<11 patientsVarious alimentary tract and metabolism products4.3%Galafold100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
9.5%Complement 5a Receptor Antagonist5.2%Tavneos100%Part D<11 patientsCalcineurin inhibitor4.3%Tacrolimus100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
Kidney International
2024 - Real-World Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis
Kidney International Reports
2024 - Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Ernest Mazzaferri, MD
The Ohio State University
Jennifer Woyach, MD
The Ohio State University
Steven Gabbe, MD
The Ohio State University
Carl Leier, MD
The Ohio State University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”